Molecular Basis of Coronavirus Virulence and Vaccine Development

This publication has 189 references indexed in Scilit:

• A live, impaired-fidelity coronavirus vaccine protects in an aged, immunocompromised mouse model of lethal disease
  Nature Medicine, 2012
• Antagonism of the Interferon-Induced OAS-RNase L Pathway by Murine Coronavirus ns2 Protein Is Required for Virus Replication and Liver Pathology
  Cell Host & Microbe, 2012
• Chimeric severe acute respiratory syndrome coronavirus (SARS-CoV) S glycoprotein and influenza matrix 1 efficiently form virus-like particles (VLPs) that protect mice against challenge with SARS-CoV
  Vaccine, 2011
• Ribose 2′-O-methylation provides a molecular signature for the distinction of self and non-self mRNA dependent on the RNA sensor Mda5
  Nature Immunology, 2011
• Immunization with an attenuated severe acute respiratory syndrome coronavirus deleted in E protein protects against lethal respiratory disease
  Virology, 2010
• A new mouse-adapted strain of SARS-CoV as a lethal model for evaluating antiviral agents in vitro and in vivo
  Virology, 2009
• Potent cross-reactive neutralization of SARS coronavirus isolates by human monoclonal antibodies
  Proceedings of the National Academy of Sciences, 2007
• Vaccines to prevent severe acute respiratory syndrome coronavirus-induced disease
  Virus Research, 2007
• Severe acute respiratory syndrome coronavirus papain-like protease: Structure of a viral deubiquitinating enzyme
  Proceedings of the National Academy of Sciences, 2006
• Identification of a new human coronavirus
  Nature Medicine, 2004